[8-4-2011] The U.S. Food and Drug Administration (FDA) is updating the public about its ongoing safety review of recombinant human growth hormone (somatropin) and possible increased […]

The FDA has issued new information about this safety issue, see the FDA Drug Safety Communication issued February 15, 2012. (en Español) Safety Announcement [1-12-2012] The […]

Safety AnnouncementAdditional Information for PatientsAdditional Information for Healthcare ProfessionalsData Summary (en Español)  Safety Announcement [01-20-2012] The U.S. Food and Drug Administration (FDA) is informing the public […]

(en Español) Safety AnnouncementAdditional Information for Patients and ConsumersAdditional Information for Healthcare ProfessionalsData Summary (Tables) Safety Announcement [02-08-2012] The U.S. Food and Drug Administration (FDA) is […]

Facts about statins and protease inhibitors Safety AnnouncementAdditional Information for PatientsAdditional Information for Healthcare ProfessionalsData SummaryStatin Dose Limitations Reference                      […]

Valproate products are FDA-approved drugs to treat seizures.  Some valproate products are also approved to treat manic or mixed episodes associated with bipolar disorder (manic-depressive disorder), or […]

The table below lists the names of products and potential signals of serious risks/new safety information that were identified for these products during the period April – June […]

The table below lists the names of products and potential signals of serious risks/new safety information that were identified for these products during the period October – […]

Adenosine is a cardiac drug that is used for the treatment of paroxysmal supraventricular tachycardia (PSVT) including that associated with accessory bypass tracts (Wolff-Parkinson-White syndrome). Adverse […]